Study could help explain why certain brain tumors don’t respond well to immunotherapy
[ad_1] BYLINE: Denise Heady Newswise — A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors…
[ad_1] BYLINE: Denise Heady Newswise — A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors…
[ad_1] Newswise — New research in colorectal cancers directed by investigators at the Johns Hopkins Kimmel Cancer Center suggests that expression of transcription factors…
[ad_1] Newswise — New Brunswick, N.J. July 1, 2023 – From the top of your head to your toes, sarcoma can grow in bones, muscles,…
[ad_1] Newswise — HOUSTON ― A blood-based test developed by researchers at The University of Texas MD Anderson Cancer Center can predict an individual’s risk of dying…
[ad_1] RESEARCH SUMMARY Study Title: Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer Publication: Journal of Clinical Oncology Dana-Farber Cancer Institute authors: Jeremiah Wala;…
[ad_1] Newswise — HOUSTON ― A new study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature…
[ad_1] Newswise — Researchers at Washington University School of Medicine in St. Louis have identified four important signs and symptoms that signal an elevated…
[ad_1] Newswise — Each year, Connecticut Magazine recognizes some of the state’s best physicians, who provide exceptional care for patients, with its annual “Top Doctors” issue.…
[ad_1] Newswise — WASHINGTON — Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for…
[ad_1] Newswise — A study in the Journal of The National Cancer Institute Cancer Spectrum looked at chatbots and artificial intelligence (AI), as they…
[ad_1] Newswise — ITHACA, N.Y. — An interdisciplinary collaboration 10 years in the making used a materials science approach to “fingerprint” the calcium mineral deposits…
[ad_1] Newswise — Philadelphia, January 20, 2023—On the journey from gene to protein, a nascent RNA molecule can be cut and joined, or spliced,…
[ad_1] Newswise — LA JOLLA, CALIF. – Jan 05, 2023 – Cosimo Commisso, Ph.D., and Susanne Heynen-Genel, Ph.D., have received a grant from the National…
[ad_1] Newswise — HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in…
[ad_1] Newswise — Every year, up to 1% of patients with chronic lymphocytic leukemia (CLL), a slow-growing blood cancer, have their disease transform into…
[ad_1] Newswise — PHILADELPHIA (December 7, 2022) – While people with cancer have options to participate in cancer clinical trials (CCTs), it can be…
[ad_1] Newswise — HOUSTON – Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three…